Literature DB >> 12560582

Effect of fusion protein cleavage site mutations on virulence of Newcastle disease virus: non-virulent cleavage site mutants revert to virulence after one passage in chicken brain.

Olav S de Leeuw1, Leo Hartog2, Guus Koch2, Ben P H Peeters1.   

Abstract

Virulence of Newcastle disease virus (NDV) is mainly determined by the amino acid sequence of the fusion (F0) protein cleavage site. Full-length NDV cDNA clone pNDFL was used to generate infectious NDV with defined mutations in the F0 cleavage site (RRQRR downward arrow L, GRQGR downward arrow F, RRQGR downward arrow F, RGQRR downward arrow F and RKQKR downward arrow F). All the mutants were viable and the mutations were maintained after virus propagation in embryonated eggs. The mutants showed single-cell infections on chicken embryo fibroblasts, which suggested that they were non-virulent. However, virulence tests in 1-day-old chickens resulted in an intracerebral pathogenicity index (ICPI) between 0 and 1.3. Moreover, virulent virus was isolated from chickens that had died in the virulence tests. Subsequent sequence analysis showed that the mutants RRQRR downward arrow L, RRQGR downward arrow F, RGQRR downward arrow F and RKQKR downward arrow F gave rise to the appearance of revertants containing the virulent cleavage site RRQ(K/R)R downward arrow F and an ICPI of 1.4 or higher. This indicated that reversion to virulence was caused by alteration of the amino acid sequence of the F0 cleavage site from a non-virulent to a virulent type. Furthermore, the ICPI of the revertants was higher than that of cDNA-derived strain NDFLtag, which has the same cleavage site, RRQRR downward arrow F (ICPI=1.3). NDFLtag(Pass), which was isolated from dead chickens after intracerebral inoculation of NDFLtag, also showed an increase in the ICPI from 1.3 to 1.5. This study proves that reversion to virulence occurs within non-virulent NDV populations and that the virulence may increase after one passage in chicken brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12560582     DOI: 10.1099/vir.0.18714-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  34 in total

1.  Characterization of a recombinant Newcastle disease virus vaccine strain.

Authors:  Sun-Hee Cho; Hyuk-Joon Kwon; Tae-Eun Kim; Jae-Hong Kim; Han-Sang Yoo; Man-Hoon Park; Young-Ho Park; Sun-Joong Kim
Journal:  Clin Vaccine Immunol       Date:  2008-09-03

Review 2.  Oncolytic viruses: From bench to bedside with a focus on safety.

Authors:  Pascal R A Buijs; Judith H E Verhagen; Casper H J van Eijck; Bernadette G van den Hoogen
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Limited evidence of intercontinental dispersal of avian paramyxovirus serotype 4 by migratory birds.

Authors:  Andrew B Reeves; Rebecca L Poulson; Denys Muzyka; Haruko Ogawa; Kunitoshi Imai; Vuong Nghia Bui; Jeffrey S Hall; Mary Pantin-Jackwood; David E Stallknecht; Andrew M Ramey
Journal:  Infect Genet Evol       Date:  2016-02-27       Impact factor: 3.342

Review 4.  Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions.

Authors:  Dmitriy Zamarin; Peter Palese
Journal:  Future Microbiol       Date:  2012-03       Impact factor: 3.165

5.  A comparative genomic and evolutionary analysis of circulating strains of Avian avulavirus 1 in Pakistan.

Authors:  Aziz-Ul Rahman; Muhammad Munir; Muhammad Zubair Shabbir
Journal:  Mol Genet Genomics       Date:  2019-05-30       Impact factor: 3.291

6.  Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease.

Authors:  Man-Seong Park; John Steel; Adolfo García-Sastre; David Swayne; Peter Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-22       Impact factor: 11.205

7.  Separate evolution of virulent newcastle disease viruses from Mexico and Central America.

Authors:  Leonardo Susta; Krishna R Hamal; Patti J Miller; Stivalis Cardenas-Garcia; Corrie C Brown; Janice C Pedersen; Victor Gongora; Claudio L Afonso
Journal:  J Clin Microbiol       Date:  2014-02-12       Impact factor: 5.948

8.  Genetic comparisons between lentogenic Newcastle disease virus isolated from waterfowl and velogenic variants.

Authors:  Ryota Tsunekuni; Hiroshi Ito; Koichi Otsuki; Hiroshi Kida; Toshihiro Ito
Journal:  Virus Genes       Date:  2009-12-12       Impact factor: 2.332

9.  Isolation of avian paramyxovirus 1 from a patient with a lethal case of pneumonia.

Authors:  Scott J Goebel; Jill Taylor; Bradd C Barr; Timothy E Kiehn; Hugo R Castro-Malaspina; Cyrus V Hedvat; Kim A Rush-Wilson; Cassandra D Kelly; Stephen W Davis; William A Samsonoff; Kelley R Hurst; Melissa J Behr; Paul S Masters
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

10.  Viable Newcastle disease vaccine strains in a pharmaceutical dump.

Authors:  Antonella Amendola; Silvia Bianchi; Marta Canuti; Alessandra Zappa; Giovanna Zanoni; Raffaella Koncan; Elisabetta Tanzi; Giuseppe Cornaglia; Alessandro Remo Zanetti; Giuseppe Tridente
Journal:  Emerg Infect Dis       Date:  2007-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.